Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$3.01 USD
-0.02 (-0.66%)
Updated Mar 24, 2023 11:32 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Shattuck Labs, Inc. (STTK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.75 | $28.00 | $9.00 | 419.80% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Shattuck Labs, Inc. comes to $15.75. The forecasts range from a low of $9.00 to a high of $28.00. The average price target represents an increase of 419.8% from the last closing price of $3.03.
Analyst Price Targets (4 )
Broker Rating
Shattuck Labs, Inc. currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80% and 20% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 20%.
Broker Rating Breakdown

Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | From | To |
---|---|---|---|---|
8/31/2022 | Btig | Research Department | Not Available | Strong Buy |
8/12/2022 | Needham & Co. | Gil J Blum | Not Available | Moderate Buy |
5/2/2022 | H C Wainwright | Joseph Pantginis | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.20 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 5 |
Average Target Price | $15.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 88 of 252 |
Current Quarter EPS Est: | -0.61 |